To enhance preventative medical capabilities and streamline public healthcare management for the 2026 fiscal year, the Ho Chi Minh City... Read more
Category: Uncategorized
Vietnamese technology conglomerate FPT and Japan’s Tokushukai Medical Group have finalized a strategic alliance focused on driving digital transformation across... Read more
Ministry of Health intensifies financial penalties on unauthorized prescription drug distribution
Effective mid-May 2026, a revised regulatory framework in Vietnam has doubled the administrative fines imposed on pharmacies selling prescription-only medications... Read more
Amgen structures financial leadership transition as CFO Peter Griffith announces retirement
Global biotechnology leader Amgen has finalized a structured executive succession plan following the announced retirement of its Chief Financial Officer... Read more
Nestle and Danone encounter regulatory pressure amid infant formula contamination updates
Global food manufacturing giants Nestle and Danone are navigating intense public and regulatory scrutiny following coordinated investigative reports published by... Read more
Global Healthcare Opportunities and CBC Group align to forge world’s largest healthcare investment entity
One of Europe’s premier healthcare-focused private equity firms, Global Healthcare Opportunities (GHO), and Asia's prominent CBC Group are merging operations... Read more
Mentari Therapeutics targets Nasdaq listing through strategic InMed merger
Privately held biotechnology innovator Mentari Therapeutics has entered into a definitive, all-stock merger agreement with InMed Pharmaceuticals (NASDAQ: INM). The... Read more
Pillr Health acquires CaptureRx to expand its federal pharmacy infrastructure footprint
Pillr Health has finalized the acquisition of San Antonio-based administrative specialist CaptureRx, effectively broadening its operational scale and federal 340B... Read more
Regeneron enters multi-billion dollar alliance with Parabilis to develop novel peptide platform
Regeneron Pharmaceuticals has finalized a comprehensive research and development collaboration valued at $2.32 billion with Parabilis Medicines. The joint initiative... Read more








